https://www.hindustantimes.com/world-news/some-weight-loss-drugs-may-increase-risk-of-gastrointestinal-diseases-canadian-study-101696592740148.html
0
0
36 words
0
Comments
GLP-1 agonists were originally developed for targeting Type 2 diabetes but have become increasingly used for weight loss regimens | World News
You are the first to view
Create an account or login to join the discussion